Multimedialna platforma wiedzy medycznej Internetowa Księgarnia Medyczna Kalendarium Konferencji
Hematology in Clinical Practice
MENU
Shortcuts Submit an article Author Guidelines Ahead Of Print Reviewers 2021

Vol 10, Supp. C (2019)

Date published: 2019-10-02

Table of Contents

open access

CASE REPORTS

Long-term response to treatment with brentuximab vedotin in a patient with relapse of Hodgkin lymphoma after auto-HSCT

Edyta Subocz, Janusz Hałka

Case report

DOI: 10.5603/Hem.2019.0023
PDF

The role of brentuximab vedotin in the treatment of patients with refractory/relapsed Hodgkin lymphoma based on two case reports

Monika Chełstowska, Krzysztof Jamroziak, Ewa Lech-Marańda, Krzysztof Warzocha

Case report

DOI: 10.5603/Hem.2019.0024
PDF

Long-term response on brentuximab vedotin therapy in patients with Hodgkin lymphoma

Andrzej Pluta, Justyna Gil, Jacek Krzanowski, Sławomir Radwański

Case report

DOI: 10.5603/Hem.2019.0020
PDF

Treatment efficacy with brentuximab vedotin in the third-line therapy of primary refractory systemic anaplastic large cell lymphoma ALK(–)

Beata Kania-Zembaczyńska

Case report

DOI: 10.5603/Hem.2019.0021
PDF

Efficacy of brentuximab vedotin in the fourth-line treatment of primary resistant Hodgkin lymphoma

Beata Kania-Zembaczyńska

Case report

DOI: 10.5603/Hem.2019.0022
PDF

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl